Department of Chemical and Biological Engineering, University of Wisconsin-Madison, USA.
Biomaterials. 2012 Oct;33(28):6783-92. doi: 10.1016/j.biomaterials.2012.05.068. Epub 2012 Jul 9.
Biologic wound dressings contain animal-derived components and are susceptible to high infection rates. To address this issue, we report an approach that permits incorporation of non-toxic levels of the small molecule antiseptic 'chlorhexidine' into biologic dressings. The approach relies on the fabrication of polyelectrolyte multilayer (PEMs) films containing poly(allylaminehydrochloride) (PAH), poly(acrylicacid) (PAA), and chlorhexidine acetate (CX) on elastomeric poly(dimethylsiloxane) (PDMS) sheets. The PEMs (20-100 nm thick) are subsequently stamped onto the wound-contact surface of a synthetic biologic dressing, Biobrane, which contains collagen peptides. Chlorhexidine loading in the PEMs was tailored by tuning the number of (CX/PAA) bilayers deposited, providing burst release of up to 0.98 ± 0.06 μg/cm(2) of CX over 24 h, followed by zero-order release of 0.35 ± 0.04 μg/cm(2)/day for another week. Although the CX concentrations released were below the reported in vitro cytotoxicity limit (5 μg/mL over 24 h) for human dermal fibroblasts, they killed 4 log(10) counts of pathogenic bacteria Staphylococcus aureus in solution. The CX/PEMs could be stamped onto Biobrane with high efficiency to provide CX release kinetics and in vitro antibacterial activity similar to that on PDMS stamps. In a full-thickness 'splinted' dermal wound-model in normal wild-type mice, the CX-functionalized Biobrane showed no decrease in either its adherence to the wound-bed or wound closure rate over 14 days. The murine wounds topically inoculated with ∼10(5) CFU/cm(2) of S. aureus and treated with CX-functionalized Biobrane demonstrated a 3 log(10) decrease in the wound's bacterial burden within 3 days, compared to persistent bacterial colonization found in wounds treated with unmodified Biobrane (n = 10 mice, p < 0.005). Overall, this study presents a promising approach to prevent bacterial colonization in wounds under biologic dressings.
生物创面敷料含有动物源性成分,易发生高感染率。为了解决这个问题,我们报告了一种方法,允许将低毒性的小分子防腐剂“洗必泰”掺入生物敷料中。该方法依赖于在弹性聚二甲基硅氧烷 (PDMS) 片上制备含有聚烯丙基胺盐酸盐 (PAH)、聚丙烯酸 (PAA) 和醋酸洗必泰 (CX) 的聚电解质多层 (PEM) 膜。然后将 PEM(20-100nm 厚)压印到合成生物敷料 Biobrane 的创面接触表面上,Biobrane 含有胶原蛋白肽。通过调整沉积的 (CX/PAA) 双层数量来调整 PEM 中的 CX 负载量,在 24 小时内提供高达 0.98±0.06μg/cm(2) 的 CX 突释释放,随后在接下来的一周内以 0.35±0.04μg/cm(2)/天的零级释放。尽管释放的 CX 浓度低于报道的人类成纤维细胞体外细胞毒性极限(24 小时内 5μg/mL),但它们在溶液中杀死了对数 4 个金黄色葡萄球菌致病性细菌的计数。CX/PEM 可以高效地压印到 Biobrane 上,以提供类似于 PDMS 压印的 CX 释放动力学和体外抗菌活性。在正常野生型小鼠的全层“夹板”真皮创面模型中,CX 功能化的 Biobrane 在 14 天内既没有降低对创面床的粘附力,也没有降低创面闭合率。在经 CX 功能化的 Biobrane 处理的小鼠创面中,局部接种约 10(5)CFU/cm(2)的金黄色葡萄球菌后,在 3 天内创面细菌负荷量降低了 3 个对数(与未改性 Biobrane 处理的创面中发现的持续细菌定植相比,n=10 只小鼠,p<0.005)。总体而言,这项研究提出了一种有前途的方法,可以防止生物敷料下的创面细菌定植。